// App-Quantinova.ai

: Is Pre-Operative CA19-9 measurement predictive of early recurrence following pancreaticoduodenectomy for pancreatic ductal adenocarcinoma?

Researchers

Presenter

  • C.L. Evans

Principal Investigators

  • E. Thompson

  • R. Saif

  • J.J. French

Medical Centers

  • Freeman Hospital

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Pancreas ductal adenocarcinoma

Biomarkers

  • Carbohydrate antigen 19-9

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Single Center

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved